| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |